Bruker Corp. PT Raised to $25.00 (BRKR)
Equities research analysts at UBS AG hoisted their target price on shares of Bruker Corp. (NASDAQ:BRKR) from $23.00 to $25.00 in a research note issued to investors on Wednesday, AnalystRatingsNetwork reports. UBS AG’s target price suggests a potential upside of 14.36% from the company’s current price.
Several other analysts have also recently commented on the stock. Analysts at ISI Group raised their price target on shares of Bruker Corp. from $23.50 to $24.50 in a research note on Wednesday. Analysts at Zacks downgraded shares of Bruker Corp. from a “neutral” rating to an “underperform” rating in a research note on Thursday, January 2nd. They now have a $18.80 price target on the stock. One research analyst has rated the stock with a sell rating, four have given a hold rating and seven have assigned a buy rating to the company. The stock has an average rating of “Buy” and an average price target of $23.53.
Shares of Bruker Corp. (NASDAQ:BRKR) traded up 2.70% during mid-day trading on Wednesday, hitting $22.45. 3,063,317 shares of the company’s stock traded hands. Bruker Corp. has a 52-week low of $15.41 and a 52-week high of $23.71. The stock’s 50-day moving average is $20.62 and its 200-day moving average is $20.01. The company has a market cap of $3.753 billion and a price-to-earnings ratio of 64.29.
Bruker Corp. (NASDAQ:BRKR) last released its earnings data on Tuesday, February 18th. The company reported $0.31 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.22 by $0.09. The company had revenue of $552.10 million for the quarter, compared to the consensus estimate of $452.14 million. On average, analysts predict that Bruker Corp. will post $0.88 earnings per share for the current fiscal year.
Bruker Corporation (NASDAQ:BRKR) is a global manufacturer of scientific instruments that address the rapidly evolving needs of a diverse array of customers in life science, pharmaceutical, biotechnology, clinical and molecular diagnostics research, as well as in materials and chemical analysis in various industries and government applications.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.